Gender differences in associations of cognitive impairments with homocysteine in schizophrenia
S Zhou, Y Huang, Q Kuang, S Yan, Y Feng, H Li… - Asian Journal of …, 2022 - Elsevier
Results There were significant differences between schizophrenia patients and healthy
controls in age (P< 0.001), BMI (P< 0.001), and education (P< 0.001). Thus, we controlled for …
controls in age (P< 0.001), BMI (P< 0.001), and education (P< 0.001). Thus, we controlled for …
COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy
Pharmacogenetic markers are current targets for the personalized treatment of psychosis.
Limited data exist on COMT and NRG1 polymorphisms in relation to risperidone treatment …
Limited data exist on COMT and NRG1 polymorphisms in relation to risperidone treatment …
COGNITIVE IMPAIRMENT IN MOOD DISORDERS: NEUROPSYCHOLOGY, MULTIMODAL BRAIN IMAGING, AND THE EFFECT OF NEUROINFLAMMATION
F Calesella - 2024 - iris.unisr.it
Il peso dei disturbi dell'umore continua a crescere, con circa un terzo dei pazienti che non
risponde agli antidepressivi. Una diagnosi accurata e tempestiva è essenziale per la …
risponde agli antidepressivi. Una diagnosi accurata e tempestiva è essenziale per la …